Global Neurorehabilitation Devices Market Report (2025–2036)
Market Overview
The Neurorehabilitation Devices market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx% globally. Rising prevalence of neurological disorders such as stroke, Parkinson’s disease, and traumatic brain injuries, coupled with advancements in robotics, brain-computer interfaces, and wearable technologies, are driving market growth. Increasing demand for personalized rehabilitation and home-based therapy solutions further supports expansion.
Impact of COVID-19
The COVID-19 pandemic disrupted rehabilitation services worldwide, delaying patient access to therapies and reducing hospital visits in 2020. However, the crisis accelerated the adoption of tele-rehabilitation, wearable monitoring devices, and AI-driven rehabilitation platforms, reshaping the industry toward remote and patient-centric solutions.
Market Segmentation
By Type
· Neurorobotic Systems (robot-assisted rehabilitation devices)
· Brain-Computer Interfaces (BCI)
· Non-invasive Stimulators (TMS, tDCS)
· Wearable Devices (exoskeletons, smart sensors)
· Virtual Reality & Augmented Reality Systems
· Others (assistive technologies, hybrid systems)
By Application
· Hospitals
· Clinics
· Rehabilitation Centers
· Homecare Settings
By Disorder
· Stroke Rehabilitation
· Parkinson’s Disease
· Traumatic Brain Injury (TBI)
· Spinal Cord Injury
· Cerebral Palsy
· Multiple Sclerosis
Regional Analysis
· North America: Leading market due to advanced healthcare infrastructure, strong R&D, and high prevalence of neurological disorders.
· Europe: Growth driven by government support for rehabilitation programs, aging population, and adoption of robotic rehabilitation systems.
· Asia-Pacific: Fastest-growing region, supported by rising healthcare investments in China, Japan, and India, and increasing awareness of neurorehabilitation.
· South America: Moderate growth, with Brazil and Argentina expanding rehabilitation facilities.
· Middle East & Africa: Emerging market with growing investments in healthcare modernization and rehabilitation technologies.
Key Players
· Medtronic PLC
· St. Jude Medical
· Agiliad
· AlterG
· Bioness Inc.
· Hocoma AG
· Ekso Bionics Holding Inc.
· Bioxtreme Robotics Rehabilitation
· Denecor
· Ectron Ltd.
· Helius Medical Technologies
· Interactive Motion Technologies
· Kinestica
· Kinetic Muscles Inc.
· Neurostyle
Additional Key Players:
· ReWalk Robotics Ltd.
· Tyromotion GmbH
· Neofect Inc.
· MindMaze SA
· Neuronetics Inc.
· Gloreha (Idrogenet)
· Rex Bionics Ltd.
· BCI Technologies Inc.
Porter’s Five Forces Analysis
· Threat of New Entrants: Moderate; high R&D costs and regulatory approvals limit entry.
· Bargaining Power of Suppliers: Moderate; specialized robotics and sensor suppliers hold leverage.
· Bargaining Power of Buyers: High; hospitals and rehabilitation centers demand cost-effective solutions.
· Threat of Substitutes: Low; neurorehabilitation devices are essential for recovery.
· Industry Rivalry: High; competition among established players drives innovation.
SWOT Analysis
Strengths: Advanced robotics, strong clinical validation, integration with AI and VR. Weaknesses: High device costs, limited access in developing regions. Opportunities: Tele-rehabilitation, homecare solutions, AI-driven personalized therapy. Threats: Regulatory hurdles, reimbursement challenges, cybersecurity risks in connected devices.
Trend Analysis
· Rising adoption of robot-assisted rehabilitation.
· Integration of VR/AR for immersive therapy experiences.
· Growth in wearable exoskeletons for mobility restoration.
· Expansion of tele-rehabilitation platforms.
· Increasing use of AI and machine learning for personalized therapy plans.
Drivers & Challenges
Drivers:
· Rising prevalence of neurological disorders.
· Technological advancements in robotics and brain-computer interfaces.
· Growing demand for home-based rehabilitation.
· Government initiatives supporting rehabilitation programs.
Challenges:
· High costs of advanced devices.
· Limited reimbursement policies.
· Shortage of trained rehabilitation professionals.
· Regulatory complexities across regions.
Value Chain Analysis
· Raw Materials: Sensors, robotics components, neurostimulation modules.
· Manufacturing: Robotics engineering, AI integration, device assembly.
· Distribution: Hospitals, clinics, rehabilitation centers, homecare providers.
· End Users: Patients, healthcare providers.
· Aftermarket Services: Device maintenance, software updates, tele-rehabilitation support.
Quick Recommendations for Stakeholders
· Manufacturers: Focus on cost-effective, portable, and AI-integrated devices.
· Healthcare Providers: Adopt tele-rehabilitation and VR-based therapies.
· Regulators: Streamline approval processes while ensuring patient safety.
· Investors: Target companies innovating in robotics and brain-computer interfaces.
· Patients: Benefit from personalized, accessible, and home-based rehabilitation solutions.
1. Market Overview of Neurorehabilitation Devices
1.1 Neurorehabilitation Devices Market Overview
1.1.1 Neurorehabilitation Devices Product Scope
1.1.2 Market Status and Outlook
1.2 Neurorehabilitation Devices Market Size by Regions:
1.3 Neurorehabilitation Devices Historic Market Size by Regions
1.4 Neurorehabilitation Devices Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Neurorehabilitation Devices Sales Market by Type
2.1 Global Neurorehabilitation Devices Historic Market Size by Type
2.2 Global Neurorehabilitation Devices Forecasted Market Size by Type
2.3 Neurorobotic System
2.4 Brain Computer Interface
2.5 Non-invasive Stimulators
2.6 Wearable Devices
2.7 Others
3. Covid-19 Impact Neurorehabilitation Devices Sales Market by Application
3.1 Global Neurorehabilitation Devices Historic Market Size by Application
3.2 Global Neurorehabilitation Devices Forecasted Market Size by Application
3.3 Hospitals
3.4 Clinics
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Neurorehabilitation Devices Production Capacity Market Share by Manufacturers
4.2 Global Neurorehabilitation Devices Revenue Market Share by Manufacturers
4.3 Global Neurorehabilitation Devices Average Price by Manufacturers
5. Company Profiles and Key Figures in Neurorehabilitation Devices Business
5.1 Medtronic PLC
5.1.1 Medtronic PLC Company Profile
5.1.2 Medtronic PLC Neurorehabilitation Devices Product Specification
5.1.3 Medtronic PLC Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.2 St. Jude Medical
5.2.1 St. Jude Medical Company Profile
5.2.2 St. Jude Medical Neurorehabilitation Devices Product Specification
5.2.3 St. Jude Medical Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.3 Agiliad
5.3.1 Agiliad Company Profile
5.3.2 Agiliad Neurorehabilitation Devices Product Specification
5.3.3 Agiliad Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.4 AlterG
5.4.1 AlterG Company Profile
5.4.2 AlterG Neurorehabilitation Devices Product Specification
5.4.3 AlterG Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.5 Bioness
5.5.1 Bioness Company Profile
5.5.2 Bioness Neurorehabilitation Devices Product Specification
5.5.3 Bioness Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.6 Hocoma AG
5.6.1 Hocoma AG Company Profile
5.6.2 Hocoma AG Neurorehabilitation Devices Product Specification
5.6.3 Hocoma AG Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.7 Ekso Bionics Holding
5.7.1 Ekso Bionics Holding Company Profile
5.7.2 Ekso Bionics Holding Neurorehabilitation Devices Product Specification
5.7.3 Ekso Bionics Holding Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.8 Bioxtreme Robotics Rehabilitation
5.8.1 Bioxtreme Robotics Rehabilitation Company Profile
5.8.2 Bioxtreme Robotics Rehabilitation Neurorehabilitation Devices Product Specification
5.8.3 Bioxtreme Robotics Rehabilitation Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.9 Denecor
5.9.1 Denecor Company Profile
5.9.2 Denecor Neurorehabilitation Devices Product Specification
5.9.3 Denecor Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.10 Ectron
5.10.1 Ectron Company Profile
5.10.2 Ectron Neurorehabilitation Devices Product Specification
5.10.3 Ectron Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.11 Helius
5.11.1 Helius Company Profile
5.11.2 Helius Neurorehabilitation Devices Product Specification
5.11.3 Helius Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.12 Interactive Motion Technologies
5.12.1 Interactive Motion Technologies Company Profile
5.12.2 Interactive Motion Technologies Neurorehabilitation Devices Product Specification
5.12.3 Interactive Motion Technologies Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.13 Kinestica
5.13.1 Kinestica Company Profile
5.13.2 Kinestica Neurorehabilitation Devices Product Specification
5.13.3 Kinestica Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.14 Kinetic Muscles
5.14.1 Kinetic Muscles Company Profile
5.14.2 Kinetic Muscles Neurorehabilitation Devices Product Specification
5.14.3 Kinetic Muscles Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
5.15 Neurostyle
5.15.1 Neurostyle Company Profile
5.15.2 Neurostyle Neurorehabilitation Devices Product Specification
5.15.3 Neurostyle Neurorehabilitation Devices Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Neurorehabilitation Devices Market Size
6.2 North America Neurorehabilitation Devices Key Players in North America
6.3 North America Neurorehabilitation Devices Market Size by Type
6.4 North America Neurorehabilitation Devices Market Size by Application
7. East Asia
7.1 East Asia Neurorehabilitation Devices Market Size
7.2 East Asia Neurorehabilitation Devices Key Players in North America
7.3 East Asia Neurorehabilitation Devices Market Size by Type
7.4 East Asia Neurorehabilitation Devices Market Size by Application
8. Europe
8.1 Europe Neurorehabilitation Devices Market Size
8.2 Europe Neurorehabilitation Devices Key Players in North America
8.3 Europe Neurorehabilitation Devices Market Size by Type
8.4 Europe Neurorehabilitation Devices Market Size by Application
9. South Asia
9.1 South Asia Neurorehabilitation Devices Market Size
9.2 South Asia Neurorehabilitation Devices Key Players in North America
9.3 South Asia Neurorehabilitation Devices Market Size by Type
9.4 South Asia Neurorehabilitation Devices Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Neurorehabilitation Devices Market Size
10.2 Southeast Asia Neurorehabilitation Devices Key Players in North America
10.3 Southeast Asia Neurorehabilitation Devices Market Size by Type
10.4 Southeast Asia Neurorehabilitation Devices Market Size by Application
11. Middle East
11.1 Middle East Neurorehabilitation Devices Market Size
11.2 Middle East Neurorehabilitation Devices Key Players in North America
11.3 Middle East Neurorehabilitation Devices Market Size by Type
11.4 Middle East Neurorehabilitation Devices Market Size by Application
12. Africa
12.1 Africa Neurorehabilitation Devices Market Size
12.2 Africa Neurorehabilitation Devices Key Players in North America
12.3 Africa Neurorehabilitation Devices Market Size by Type
12.4 Africa Neurorehabilitation Devices Market Size by Application
13. Oceania
13.1 Oceania Neurorehabilitation Devices Market Size
13.2 Oceania Neurorehabilitation Devices Key Players in North America
13.3 Oceania Neurorehabilitation Devices Market Size by Type
13.4 Oceania Neurorehabilitation Devices Market Size by Application
14. South America
14.1 South America Neurorehabilitation Devices Market Size
14.2 South America Neurorehabilitation Devices Key Players in North America
14.3 South America Neurorehabilitation Devices Market Size by Type
14.4 South America Neurorehabilitation Devices Market Size by Application
15. Rest of the World
15.1 Rest of the World Neurorehabilitation Devices Market Size
15.2 Rest of the World Neurorehabilitation Devices Key Players in North America
15.3 Rest of the World Neurorehabilitation Devices Market Size by Type
15.4 Rest of the World Neurorehabilitation Devices Market Size by Application
16 Neurorehabilitation Devices Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Market Segmentation
By Type
· Neurorobotic Systems (robot-assisted rehabilitation devices)
· Brain-Computer Interfaces (BCI)
· Non-invasive Stimulators (TMS, tDCS)
· Wearable Devices (exoskeletons, smart sensors)
· Virtual Reality & Augmented Reality Systems
· Others (assistive technologies, hybrid systems)
By Application
· Hospitals
· Clinics
· Rehabilitation Centers
· Homecare Settings
By Disorder
· Stroke Rehabilitation
· Parkinson’s Disease
· Traumatic Brain Injury (TBI)
· Spinal Cord Injury
· Cerebral Palsy
· Multiple Sclerosis
